Literature DB >> 18978362

Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.

F Laurent, A Tristan, M Croze, M Bes, H Meugnier, G Lina, F Vandenesch, J Etienne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18978362     DOI： 10.1093/jac/dkn456

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  Association of recurrent furunculosis with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus.

Authors:  Helena Masiuk; Katarzyna Kopron; Dorothee Grumann; Christiane Goerke; Julia Kolata; Joanna Jursa-Kulesza; Stefania Giedrys-Kalemba; Barbara M Bröker; Silva Holtfreter
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

2.  [Pediatric dermatology. New aspects of bacterial skin infections in children].

Authors:  H Hofmann; C Schnopp
Journal:  Hautarzt       Date:  2009-03       Impact factor: 0.751

3.  Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014.

Authors:  David J Farrell; Rodrigo E Mendes; Mariana Castanheira; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

4.  Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents.

Authors:  Antonio Torrelo; Ramon Grimalt; Xavier Masramon; Núria Albareda López; Ilonka Zsolt
Journal:  Dermatology       Date:  2020-01-20       Impact factor: 5.366

5.  The use of typing methods and infection prevention measures to control a bullous impetigo outbreak on a neonatal ward.

Authors:  Maike Koningstein; Leon Groen; Kathelijn Geraats-Peters; Suzanne Lutgens; Ariene Rietveld; Petr Jira; Jan Kluytmans; Sabine C de Greeff; Mirjam Hermans; Peter M Schneeberger
Journal:  Antimicrob Resist Infect Control       Date:  2012-11-20       Impact factor: 4.887

6.  Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.

Authors:  Fangyou Yu; Yunling Liu; Chaohui Lu; Jinnan Lv; Xiuqin Qi; Yu Ding; Dan Li; Xiaoying Huang; Longhua Hu; Liangxing Wang
Journal:  BMC Microbiol       Date:  2015-10-13       Impact factor: 3.605

7.  The global prevalence of fusidic acid resistance in clinical isolates of Staphylococcus aureus: a systematic review and meta-analysis.

Authors:  Mehdi Goudarzi; Bahareh Hajikhani; Sareh Kakavandi; Sana Amini; Samira Zamani; Alex van Belkum; Hossein Goudarzi; Masoud Dadashi
Journal:  Antimicrob Resist Infect Control       Date:  2021-05-01       Impact factor: 6.454

8.  Subpopulations of Staphylococcus aureus clonal complex 121 are associated with distinct clinical entities.

Authors:  Kevin Kurt; Jean-Philippe Rasigade; Frederic Laurent; Richard V Goering; Helena Žemličková; Ivana Machova; Marc J Struelens; Andreas E Zautner; Silva Holtfreter; Barbara Bröker; Stephen Ritchie; Sin Reaksmey; Direk Limmathurotsakul; Sharon J Peacock; Christiane Cuny; Franziska Layer; Wolfgang Witte; Ulrich Nübel
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.